Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

shutterstock_212432119

Morphosys, Novartis and Galaagos shut down development of atopic dermatitis candidate

October 31, 2019 Research and Development Galapagos, Novartis, atopic dermatitis, morphosys, pharma

The trio of Galapagos, MorphoSys and Novartis Pharma has revealed that all further development of its MOR106 drug candidate for …
News
david_eatwell

Genmab’s Executive VP and CFO to retire in 2020

October 31, 2019 Research and Development Genmab, appointment, pharma

David Eatwell, Executive Vice President and Chief Financial Officer at Genmab, has announced his intention to step down from the …
News
pharmafocus_november_2019_front_cover

The November 2019 issue of Pharmafocus is available to read for free online now!

October 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The latest monthly edition of Pharmafocus, the November issue, is available to read for free online now!
News

FDA approves Biogen and Alkermes’ Vumerity for relapsing multiple sclerosis

October 30, 2019 Research and Development, Sales and Marketing Alkermes, Biogen, FDA, Vumerity, multiple sclerosis, pharma

The FDA has given the green light to Vumerity (diroximel fumarate), a novel oral fumarate developed by Biogen and Alkermes, …
News

FDA slams brakes on trial for world’s most expensive drug following safety concerns in children

October 30, 2019 Research and Development FDA, Novartis, Zolgensma, pharma

The FDA has temporarily shut down a clinical trial evaluating Zolgensma – the world’s most expensive drug at $3.1 million …
News

Expanded EU label for Benlyta now covers paediatric lupus patients

October 30, 2019 Research and Development, Sales and Marketing Benlyta, Europe, GSK, Lupus, pharma

GlaxoSmithKline is celebrating the news that the European Commission has chosen to approve an expansion to the label of its …
News

European Commission approves Sanofi’s Dupixent in chronic rhinosinusitis with nasal polyposis

October 30, 2019 Research and Development, Sales and Marketing Dupixent, EU, Sanofi, pharma

Sanofi’s Dupixent (dupilumab) has secured European approval for the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP), it has emerged. …
News
gsk_boronia_australia

GSK’s tuberculosis vaccine shows efficacy over three years in HIV negative patients

October 29, 2019 Manufacturing and Production, Research and Development GSK, IAVI, Vaccine, pharma, tuberculosis

Promising results have been revealed from a GlaxoSmithKline study, conducted in partnership with non-profit scientific research organisation IAVI, investigating the …
News

AstraZeneca’s Imfinzi triple combo beats chemo in treatment-naive metastatic lung cancer

October 29, 2019 Manufacturing and Production, Research and Development AstraZeneca, Cancer, Imfinzi, NSCLC, lung cancer, pharma

AstraZeneca has unveiled positive new Phase 3 data for the combination of Imfinzi (durvalumab) and anti-CTLA4 antibody tremelimumab with chemotherapy …
News
shutterstock_339308225

Deeper patient insights for stronger patient outcomes

October 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eyeforpharma, pharma

Patient insights are crucial. As you already know, they are the key to the creation of successful, targeted programmes and …
News
gilead-sciences

Gilead’s filgotinib combos fall short in lupus and Sjögren’s syndrome

October 28, 2019 Research and Development, Sales and Marketing Gilead, Lupus, filgotinib, pharma

Gilead’s impending regulatory submission of its JAK inhibitor filgotinib to the FDA for the treatment of rheumatoid arthritis has been …
News
shutter

UKRI and BBSRC award £170m to 3 UK universities for biotech and biology PhD studentships

October 28, 2019 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, pharma, research

The Biotechnology and Biological Sciences Research Council (BBSRC) and UK Research and Innovation (UKRI) have awarded a funding injection of …
News
top_10_photo

Top Ten most popular articles on Pharmafile.com this week

October 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s another end of the week here at Pharmafile and here we run down our top 10 articles and features …
News

FlyPharma tackles supply chain challenges and industry best practice at another successful conference

October 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flypharma, pharma

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges …
News
pliant

Novartis enters license agreement with Pliant Therapeutics for fibrosis assets

October 24, 2019 Research and Development

Novartis has signed a collaboration and license agreement with Pliant Therapeutics to develop and commercialise preclinical asset PLN-1474 which is …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026